Zohreh Farsi
Group Leader, Research Scientist I Broad Institute
Zohreh Farsi is a Senior Group Leader at the Stanley Center for Psychiatric Research at the Broad Institute of MIT and Harvard, where she leads efforts to translate human genetics into novel therapeutic strategies for psychiatric disorders. She received her M.Sc. and Ph.D. in Neuroscience from the Max Planck Institutes in Göttingen, Germany, and completed her postdoctoral training in Dr. Morgan Sheng’s laboratory at the Broad Institute. Dr. Farsi’s work focuses on leveraging genetic disease models and multi-omics approaches to identify and validate drug targets for schizophrenia. She has developed a scalable pipeline that integrate transcriptomic and proteomic data to prioritize therapeutic opportunities and is currently leading multiple programs advancing novel targets toward preclinical development.
Seminars
- Leveraging large‑scale human genetics to define biologically grounded entry points for schizophrenia and bipolar disorder
- Designing next‑generation animal models that capture disease‑relevant circuits and synaptic phenotypes rather than surface behaviors alone
- Using genetically informed models to distinguish causal mechanisms from downstream correlates in psychotic disorders
- How genetics‑anchored models can enable more rational discovery of novel drug targets and translational biomarkers
